Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Neurointerventional Procedural Medical Device Market in China 2021
15 March 2021
The neurointerventional procedural medical device market in China in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 20.1% during the forecast period, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for neurointerventional procedural medical device. The China neurointerventional procedural medical device market is segmented on the basis of type. By type, it is categorized into hemorrhage, and ischemia.
The report has profiled some of the key players of the market such as MicroPort Scientific Corporation, Medtronic plc, Penumbra Inc., Stryker Corporation.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the neurointerventional procedural medical device market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Type: hemorrhage, and ischemia
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the China neurointerventional procedural medical device market
Pinpoint growth sectors and trends for investment
Understand what the future of the neurointerventional procedural medical device market in China looks like
Identify the competitive landscape and window of opportunity
Table of Contents
1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Neurointerventional Procedural Medical Device Market by Type
5. Company Profiles
5.1 MicroPort Scientific Corporation
5.2 Medtronic plc
5.3 Penumbra, Inc.
5.4 Stryker Corporation
6.1 About StrategyHelix